- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: The FEBS journal(290), H. 1, S.93-111
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2023
- Urheber
-
Werny, Ludwig
Grogro, Antonia
Bickenbach, Kira
Bülck, Cynthia Celine
Armbrust, Fred
Koudelka, Tomas
Pathak, Kriti
Scharfenberg, Franka
Sammel, Martin
Sheikhouny, Farah
Tholey, Andreas
Linder, Stefan
Becker-Pauly, Christoph
- DOI
-
10.1111/febs.16586
- URN
-
urn:nbn:de:gbv:8:3-2023-00336-9
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Werny, Ludwig
- Grogro, Antonia
- Bickenbach, Kira
- Bülck, Cynthia Celine
- Armbrust, Fred
- Koudelka, Tomas
- Pathak, Kriti
- Scharfenberg, Franka
- Sammel, Martin
- Sheikhouny, Farah
- Tholey, Andreas
- Linder, Stefan
- Becker-Pauly, Christoph
- Universitätsbibliothek Kiel
Entstanden
- 2023
Ähnliche Objekte (12)
LRP1 shedding in human brain: roles of ADAM10 and ADAM17
Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Das ADAM10-vermittelte Shedding des Prionproteins - mechanistische Aspekte und die Rolle in Prionerkrankungen
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
Einfluss von äußeren Faktoren und Insulin auf die Shedding-Aktivität der Proteasen ADAM10 und ADAM17
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding
Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes
Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
LRP1 shedding in human brain: roles of ADAM10 and ADAM17
Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Das ADAM10-vermittelte Shedding des Prionproteins - mechanistische Aspekte und die Rolle in Prionerkrankungen
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
Einfluss von äußeren Faktoren und Insulin auf die Shedding-Aktivität der Proteasen ADAM10 und ADAM17
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding
Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes
Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
LRP1 shedding in human brain: roles of ADAM10 and ADAM17
Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
Das ADAM10-vermittelte Shedding des Prionproteins - mechanistische Aspekte und die Rolle in Prionerkrankungen
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
Einfluss von äußeren Faktoren und Insulin auf die Shedding-Aktivität der Proteasen ADAM10 und ADAM17
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding
Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes
Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein